Properties of RNA polymerases from B16 melanoma.
D000645:Ammonium Sulfate / Q000494:pharmacology; D000818:Animals; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology; D002843:Chromatin / Q000502:physiology; D004247:DNA / Q000494:pharmacology; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D008545:Melanoma / Q000201:enzymology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology; D009374:Neoplasms, Experimental / Q000201:enzymology*; D009711:Nucleotides / Q000494:pharmacology; D010740:Phospholipases / Q000494:pharmacology; D012997:Solvents / Q000494:pharmacology
D002843:Chromatin; D009711:Nucleotides; D012997:Solvents; D008345:Manganese; D004247:DNA; D012321:DNA-Directed RNA Polymerases; D010740:Phospholipases; D008274:Magnesium; D000645:Ammonium Sulfate